Editing Flunitrazepam (section)

====Recreational use====
A 1989 article in the ''[[European Journal of Clinical Pharmacology]]'' reports that benzodiazepines accounted for 52% of prescription forgeries in [[Sweden]], suggesting that benzodiazepines were a major prescription drug class of abuse. [[Nitrazepam]] accounted for 13% of forged prescriptions, and accounted for 44% of forgeries specifically for benzodiazepines while flunitrazepam, diazepam, and oxazepam accounted for the majority of the rest of benzodiazepine forgeries. Prescription forgeries for other benzodiazepines marketed in Sweden (alprazolam, clonazepam, lorazepam, clobazam, and bromazepam) were negligible. When calculated in relation to utilization, the narcotic analgesics codeine, pentazocine, and ketobemidone were at the top of the list for the highest number of overall prescription forgeries, suggesting a higher abuse potential of these drugs.<ref>{{cite journal | vauthors = Bergman U, Dahl-Puustinen ML | title = Use of prescription forgeries in a drug abuse surveillance network | journal = European Journal of Clinical Pharmacology | volume = 36 | issue = 6 | pages = 621–623 | date = November 1989 | pmid = 2776820 | doi = 10.1007/BF00637747 | s2cid = 19770310 }}</ref> In neighboring [[Finland]], temazepam accounts for roughly 40–50% benzodiazepine prescription forgeries annually, while flunitrazepam accounts for approximately ~15% of benzodiazepine prescription forgeries.<ref name="Europedrugs">{{cite web|title=Classification of controlled drugs|url=http://www.emcdda.europa.eu/html.cfm/index146601EN.html|publisher=EMCDDA|access-date=30 June 2022}}</ref>

Flunitrazepam and other sedative hypnotic drugs are detected frequently in cases of people suspected of driving under the influence of drugs. Other benzodiazepines and nonbenzodiazepines ([[anxiolytic]] or [[hypnotic]]) such as [[zolpidem]] and [[zopiclone]] (as well as [[cyclopyrrolones]], [[imidazopyridine]]s, and [[pyrazolopyrimidine]]s) are also found in high numbers of suspected drugged drivers. Many drivers have blood levels far exceeding the therapeutic dose range, suggesting a high degree of [[abuse potential|potential for addiction]] for benzodiazepines and similar drugs.<ref>{{cite journal | vauthors = Jones AW, Holmgren A, Kugelberg FC | title = Concentrations of scheduled prescription drugs in blood of impaired drivers: considerations for interpreting the results | journal = Therapeutic Drug Monitoring | volume = 29 | issue = 2 | pages = 248–260 | date = April 2007 | pmid = 17417081 | doi = 10.1097/FTD.0b013e31803d3c04 | s2cid = 25511804 }}</ref>